Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients.
cardiac resynchronization therapy
endocarditis
heart failure
signs
symptoms
Journal
Archives of medical science : AMS
ISSN: 1734-1922
Titre abrégé: Arch Med Sci
Pays: Poland
ID NLM: 101258257
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
02
2018
accepted:
04
04
2018
entrez:
24
5
2021
pubmed:
7
8
2018
medline:
7
8
2018
Statut:
epublish
Résumé
The aim of the study was to analyse microbiological characteristics and clinical manifestations of cardiac device-related infective endocarditis (CDRIE) in cardiac resynchronization therapy (CRT) recipients, and to compare the diagnostic value of modified Duke (MDC) versus modified Duke lead criteria (MDLC; including to MDC local infection and pulmonary infection or embolism as major criteria). The study population comprised 765 consecutive CRT patients from a high-volume, tertiary care centre from 2002 to 2015. All patients were screened for CDRIE. During a median follow-up of 1692 days (range: 457-3067) 5.36% of patients ( Fever is the most common symptom of CRT-related CDRIE, and transoesophageal echocardiography allows vegetations to be visualised in nearly 3/4 of patients with CDRIE. Although the most common pathogens were
Identifiants
pubmed: 34025833
doi: 10.5114/aoms.2018.75893
pii: 89758
pmc: PMC8130459
doi:
Types de publication
Journal Article
Langues
eng
Pagination
638-645Informations de copyright
Copyright: © 2018 Termedia & Banach.
Déclaration de conflit d'intérêts
Ewa Jędrzejczyk-Patej, Michał Mazurek, Oskar Kowalski, Agnieszka Liberska - consultant fees from Biotronik, Medtronic, St Jude Medical and Boston Scientific; Adam Sokal - travels reimbursement and consultant fees from Biotronik, Medtronic, St Jude Medical and Boston Scientific; lecturers from Medtronic, Boston Scientific and Impulse Dynamics; Radosław Lenarczyk –consultant fees and lecturers for Biotronik, Medtronic, St Jude Medical and Boston Scientific; Cordis Webster, Boeingher Ingelheim; Tomasz Podolecki – consultant fees from St Jude, Adamed, Abbott; Zbigniew Kalarus – received company sponsored speaker’s bureau from Pfizer, Eli Lilly, Boehringer-Ingelheim, Abbott, Bayer; travel expenses to cardiology congresses from St. Jude Medical and Adamed; advisory committee: Boehringer-Ingelheim, Amgen, Astra Zeneca; Other authors – no conflict of interests reported.
Références
Europace. 2013 Jan;15(1):89-100
pubmed: 22968846
Circulation. 1997 Apr 15;95(8):2098-107
pubmed: 9133520
J Am Coll Cardiol. 2012 Feb 14;59(7):681-7
pubmed: 22322085
Europace. 2012 Sep;14(9):1334-9
pubmed: 22399202
Eur J Heart Fail. 2001 Aug;3(4):415-21
pubmed: 11511426
Europace. 2013 Jan;15(1):66-70
pubmed: 23097224
J Interv Card Electrophysiol. 2011 Aug;31(2):171-83
pubmed: 21365264
J Am Coll Cardiol. 2002 Jul 3;40(1):111-8
pubmed: 12103264
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
JACC Cardiovasc Imaging. 2014 Jun;7(6):541-9
pubmed: 24813965
Int J Cardiol. 2017 Jan 15;227:18-24
pubmed: 27846457
Arch Med Sci. 2017 Aug;13(5):1069-1077
pubmed: 28883848
Heart Rhythm. 2010 Aug;7(8):1043-7
pubmed: 20470904
Heart Rhythm. 2017 Jan;14(1):43-49
pubmed: 27725287
Circulation. 2010 Jan 26;121(3):458-77
pubmed: 20048212
Heart. 2012 May;98(9):724-31
pubmed: 22523057
Heart. 1999 Jan;81(1):82-7
pubmed: 10220550
Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1601-8
pubmed: 24791953
Arch Med Sci. 2017 Aug;13(5):1006-1017
pubmed: 28883840
Pol Arch Med Wewn. 2016 Apr 13;126(4):275-83
pubmed: 27074692
Eur J Heart Fail. 2012 Jun;14(6):628-34
pubmed: 22552183
J Antimicrob Chemother. 2015 Feb;70(2):325-59
pubmed: 25355810
Circulation. 1994 Jun;89(6):2684-7
pubmed: 8205682
Arch Med Sci. 2016 Apr 1;12(2):349-52
pubmed: 27186179
Mayo Clin Proc. 2008 Jan;83(1):46-53
pubmed: 18174000
Pacing Clin Electrophysiol. 2008 May;31(5):548-53
pubmed: 18439167
N Engl J Med. 2010 Dec 16;363(25):2385-95
pubmed: 21073365
Am Heart J. 2004 Apr;147(4):582-6
pubmed: 15077071